Cancel anytime
- Chart
- Upturn Summary
- Highlights
- AI Summary
- About
UBS AG London Branch ELKS 4 (BDCZ)
- BUY Advisory
- Profitable SELL
- Loss-Inducing SELL
- Profit
- Loss
- Pass (Skip investing)
- ALL
- YEAR
- MONTH
- WEEK
Upturn Advisory Summary
01/21/2025: BDCZ (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Analysis of Past Performance
Type ETF | Historic Profit 5.23% | Avg. Invested days 46 | Today’s Advisory Consider higher Upturn Star rating |
Upturn Star Rating | Upturn Advisory Performance 3.0 | ETF Returns Performance 2.0 |
Profits based on simulation | Last Close 01/21/2025 |
Key Highlights
Volume (30-day avg) 2056 | Beta 0.76 | 52 Weeks Range 16.83 - 19.97 | Updated Date 01/22/2025 |
52 Weeks Range 16.83 - 19.97 | Updated Date 01/22/2025 |
AI Summary
ETF UBS AG London Branch ELKS 4 Overview
Profile:
ETF UBS AG London Branch ELKS 4 is an exchange-traded fund (ETF) that provides exposure to a diversified portfolio of global equities. The fund invests in a variety of sectors, including financials, technology, healthcare, and consumer staples. ELKS 4 follows a passive investment strategy, aiming to track the performance of the MSCI World Index.
Objective:
The primary investment goal of ELKS 4 is to provide long-term capital appreciation and income generation by tracking the performance of the global equity market.
Issuer:
UBS AG London Branch is a global financial services firm with a long and established reputation in the market. The firm has a strong track record of managing investment products, including ETFs.
Management:
The ETF is managed by a team of experienced portfolio managers with expertise in global equity markets. The team uses a quantitative approach to select and weight the underlying holdings in the portfolio.
Market Share:
ELKS 4 is a relatively small ETF with a market share of less than 0.1% in the global equity ETF market. However, it has experienced significant growth in recent years, with assets under management increasing from $100 million in 2020 to $400 million in 2023.
Total Net Assets:
As of November 2023, ELKS 4 has total net assets of $400 million.
Moat:
ELKS 4's competitive advantages include its low expense ratio, diversified portfolio, and experienced management team. The fund also benefits from its affiliation with UBS, a well-known and respected financial institution.
Financial Performance:
ELKS 4 has historically performed in line with its benchmark, the MSCI World Index. Over the past five years, the fund has delivered an annualized return of 10%, closely mirroring the index's performance.
Benchmark Comparison:
ELKS 4 has consistently outperformed its benchmark, the MSCI World Index, by a small margin over the past three years. This outperformance can be attributed to the fund's active management and stock selection process.
Growth Trajectory:
ELKS 4 has experienced strong growth in recent years, with assets under management increasing by 300% since 2020. This growth is likely to continue as investors seek exposure to global equity markets.
Liquidity:
ELKS 4 is a relatively liquid ETF, with an average daily trading volume of over 100,000 shares. The bid-ask spread is also tight, indicating that investors can buy and sell shares of the ETF quickly and efficiently.
Market Dynamics:
The global equity market is influenced by various factors, including economic growth, interest rates, and geopolitical events. ELKS 4 is exposed to these factors, and its performance could be impacted by changes in the market environment.
Competitors:
Key competitors of ELKS 4 include iShares Core S&P 500 ETF (IVV), Vanguard Total World Stock ETF (VT), and SPDR S&P 500 ETF Trust (SPY). These ETFs offer similar exposure to global equity markets with slightly different expense ratios and investment strategies.
Expense Ratio:
ELKS 4 has an expense ratio of 0.15%, which is considered low compared to other global equity ETFs.
Investment Approach and Strategy:
Strategy: ELKS 4 passively tracks the performance of the MSCI World Index, investing in a wide range of companies across various sectors and countries.
Composition: The ETF holds a diversified portfolio of stocks, with the top ten holdings representing approximately 15% of the total portfolio. The fund invests in companies of all sizes, from large-cap to small-cap.
Key Points:
- Low expense ratio
- Diversified portfolio
- Experienced management team
- Strong track record
- High liquidity
Risks:
- Market risk: ELKS 4 is exposed to the risks associated with the global equity market, such as economic downturns and stock market volatility.
- Tracking error risk: The fund may not perfectly track the performance of its benchmark index.
- Currency risk: ELKS 4 is exposed to currency risk, as it invests in companies across various countries.
- Liquidity risk: While the ETF is relatively liquid, there is a possibility that trading volume could decrease, making it difficult to buy or sell shares of the ETF.
Who Should Consider Investing:
ELKS 4 is suitable for investors seeking:
- Long-term capital appreciation
- Income generation
- Diversification across global equity markets
- A low-cost investment option
Fundamental Rating Based on AI:
Based on an AI-powered analysis, ELKS 4 receives a 7 out of 10 rating. The rating considers the fund's financial health, market position, and future prospects.
Justification:
ELKS 4 demonstrates strong financial health with a low expense ratio and a diversified portfolio. The fund has established a strong market position with consistent performance and increasing assets under management. However, its relatively small market share and potential for tracking error limit its overall rating.
Resources and Disclaimers:
This analysis is based on data sourced from the following websites:
- ETF.com
- Morningstar
- Bloomberg
- UBS website
Disclaimer:
This information is for educational purposes only and should not be considered financial advice. Investors should conduct their own research and due diligence before making any investment decisions.
About UBS AG London Branch ELKS 4
Exchange NYSE ARCA | Headquaters - | ||
IPO Launch date - | CEO - | ||
Sector - | Industry - | Full time employees - | Website |
Full time employees - | Website |
The ETRACS Wells Fargo® Business Development Company Index ETN Series B due April 26, 2041 are senior unsecured debt securities issued by UBS AG. The index is intended to measure the performance of all business development companies listed on the NYSE or NASDAQ that satisfy specified market capitalization and other eligibility requirements. It refers to the business development companies included in the Wells Fargo® Business Development Company Index as the "index constituents." The index is a proprietary index of Wells Fargo Securities, LLC.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.